Literature DB >> 33514641

Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer.

Paul Gueguen1, Christina Metoikidou1, Thomas Dupic2, Myriam Lawand1, Christel Goudot1, Sylvain Baulande3, Sonia Lameiras3, Olivier Lantz1,4, Nicolas Girard5, Agathe Seguin-Givelet6,7, Marine Lefevre6, Thierry Mora8, Aleksandra M Walczak9, Joshua J Waterfall10,11, Sebastian Amigorena12.   

Abstract

Tumor-infiltrating lymphocytes (TILs), in general, and especially CD8+ TILs, represent a favorable prognostic factor in non-small cell lung cancer (NSCLC). The tissue origin, regenerative capacities, and differentiation pathways of TIL subpopulations remain poorly understood. Using a combination of single-cell RNA and T cell receptor (TCR) sequencing, we investigate the functional organization of TIL populations in primary NSCLC. We identify two CD8+ TIL subpopulations expressing memory-like gene modules: one is also present in blood (circulating precursors) and the other one in juxtatumor tissue (tissue-resident precursors). In tumors, these two precursor populations converge through a unique transitional state into terminally differentiated cells, often referred to as dysfunctional or exhausted. Differentiation is associated with TCR expansion, and transition from precursor to late-differentiated states correlates with intratumor T cell cycling. These results provide a coherent working model for TIL origin, ontogeny, and functional organization in primary NSCLC.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2021        PMID: 33514641     DOI: 10.1126/sciimmunol.abd5778

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  17 in total

Review 1.  TCR-sequencing in cancer and autoimmunity: barcodes and beyond.

Authors:  Kristen E Pauken; Kaitlyn A Lagattuta; Benjamin Y Lu; Liliana E Lucca; Adil I Daud; David A Hafler; Harriet M Kluger; Soumya Raychaudhuri; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2022-01-25       Impact factor: 16.687

2.  Discovering dominant tumor immune archetypes in a pan-cancer census.

Authors:  Alexis J Combes; Bushra Samad; Jessica Tsui; Nayvin W Chew; Peter Yan; Gabriella C Reeder; Divyashree Kushnoor; Alan Shen; Brittany Davidson; Andrea J Barczak; Michael Adkisson; Austin Edwards; Mohammad Naser; Kevin C Barry; Tristan Courau; Taymour Hammoudi; Rafael J Argüello; Arjun Arkal Rao; Adam B Olshen; Cathy Cai; Jenny Zhan; Katelyn C Davis; Robin K Kelley; Jocelyn S Chapman; Chloe E Atreya; Amar Patel; Adil I Daud; Patrick Ha; Aaron A Diaz; Johannes R Kratz; Eric A Collisson; Gabriela K Fragiadakis; David J Erle; Alexandre Boissonnas; Saurabh Asthana; Vincent Chan; Matthew F Krummel
Journal:  Cell       Date:  2021-12-27       Impact factor: 41.582

3.  Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.

Authors:  Carmen M Anadon; Xiaoqing Yu; Kay Hänggi; Subir Biswas; Ricardo A Chaurio; Alexandra Martin; Kyle K Payne; Gunjan Mandal; Patrick Innamarato; Carly M Harro; Jessica A Mine; Kimberly B Sprenger; Carla Cortina; John J Powers; Tara Lee Costich; Bradford A Perez; Chandler D Gatenbee; Sandhya Prabhakaran; Douglas Marchion; Mirjam H M Heemskerk; Tyler J Curiel; Alexander R Anderson; Robert M Wenham; Paulo C Rodriguez; Jose R Conejo-Garcia
Journal:  Cancer Cell       Date:  2022-04-14       Impact factor: 38.585

Review 4.  Emerging concepts in PD-1 checkpoint biology.

Authors:  Kristen E Pauken; James A Torchia; Apoorvi Chaudhri; Arlene H Sharpe; Gordon J Freeman
Journal:  Semin Immunol       Date:  2021-05-15       Impact factor: 11.130

5.  hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p.

Authors:  Wei Jiang; Yaozhou He; Zijian Ma; Yu Zhang; Chengpeng Zhang; Nianpeng Zheng; Xing Tang
Journal:  Cell Death Discov       Date:  2021-05-28

6.  Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA).

Authors:  Stefan A Schattgen; Kate Guion; Jeremy Chase Crawford; Aisha Souquette; Alvaro Martinez Barrio; Michael J T Stubbington; Paul G Thomas; Philip Bradley
Journal:  Nat Biotechnol       Date:  2021-08-23       Impact factor: 68.164

7.  Participation of Increased Circulating MAIT Cells in Lung Cancer: a Pilot Study.

Authors:  Qian Zhang; Pengli Li; Wenqin Zhou; Shu Fang; Jiong Wang
Journal:  J Cancer       Date:  2022-03-06       Impact factor: 4.207

Review 8.  Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.

Authors:  Hiroyasu Aoki; Shigeyuki Shichino; Kouji Matsushima; Satoshi Ueha
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

9.  G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes.

Authors:  Chunwan Lu; Dafeng Yang; John D Klement; Yolonda L Colson; Nicholas H Oberlies; Cedric J Pearce; Aaron H Colby; Mark W Grinstaff; Han-Fei Ding; Huidong Shi; Kebin Liu
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

10.  Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.

Authors:  Angela Pizzolla; Simon Paul Keam; Ismael A Vergara; Franco Caramia; Niko Thio; Minyu Wang; Nikolce Kocovski; Daniela Tantalo; Jafar Jabbari; George Au-Yeung; Shahneen Sandhu; David E Gyorki; Alison Weppler; Maurizio Perdicchio; Grant A McArthur; Anthony T Papenfuss; Paul Joseph Neeson
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.